As a leader in pharmaceutical research, we are committed to helping patients gain access to the breakthrough medicines we discover. GlaxoSmithKline patient assistance programs provided medicines valued at over $507 million (Wholesale Acquisition Cost) to 466,000 patients during 2009. We offer many of our medicines free, or nearly free, for those who qualify. GSK has three programs in the U.S. that are designed to meet this need:
Bridges to Access– Bridges to Access provides GSK non-oncology prescription medicines to eligible low-income patients who do not have prescription drug benefits.
Commitment to Access – Commitment to Access is GlaxoSmithKline’s patient assistance program for oncology and specialty products. Eligible patients may receive GSK oncology and specialty pharmacy products at no cost.
GSK Access – GSK Access provides eligible Medicare Part D Prescription Drug plan enrollees GSK non-oncology products at no cost. (For information on assistance for oncology and specialty pharmacy products please visit CommitmentToAccess.com).
GSK Vaccines Access Program – GSK Vaccines Access Program provides GlaxoSmithKline vaccines to adult applicants who meet eligibility requirements.
GSK Co-Pay Assistance Program – GSK Co-Pay Assistance Program is a patient assistance program sponsored by GlaxoSmithKline that helps eligible patients pay insurance copayments for certain GSK oncology medicines.
To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.
